Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

NTLANTLA
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in INTELLIA THERAPEUTICS INC

Yes. BNP Paribas Financial Markets holds 577,825 shares of NTLA (Intellia Therapeutics), worth $9.8M, as of its Q2 2026 13F filing. It reduced the position by 1,605 shares (-0.3%) from Q1 2026. BNP Paribas Financial Markets has held NTLA in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$9.8M

Current Shares

577,825

Total Value Change

+$4.7M

Total Shares Change

+331,463

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
577,825
-0.3%
$9.8M0.0%$16.92
0
2026-Q1
Decreased
579,430
-2.0%
$7.4M0.0%$12.82
0
2025-Q4
Increased
591,277
+1076.7%
$5.3M0.0%$8.99
44
2025-Q3
Decreased
50,251
-88.2%
$867,8350.0%$17.27
0
2025-Q2
Increased
426,667
+25.3%
$4M0.0%$9.38
33
2025-Q1
Decreased
340,457
-22.4%
$2.4M0.0%$7.11
0
2024-Q4
Increased
438,458
+78.0%
$5.1M0.0%$11.66
41
2024-Q3
Increased
246,362
+88.0%
$5.1M0.0%$20.55
42

Other major holders of NTLA: ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used